Clinical trial
Safety and Feasibility of a Malaria Transmission Model in Semi-immune Kenyan Adults Using Plasmodium Falciparum Sporozoites
NCT04280692 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Feasibility of a Malaria Transmission Model in Semi-immune Kenyan Adults Using Plasmodium Falciparum Sporozoites
- Lead sponsor
- University of Oxford
- Phase
- Phase 1/2
- Overall status
- Suspended
- Start date
- August 22, 2022
- Completion date
- August 31, 2026
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
malaria,falciparum